{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T10:52:26Z","timestamp":1776941546107,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1124\/jpet.121.000566","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T17:15:39Z","timestamp":1620407739000},"page":"42-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["\u03b3-Hydroxybutyric Acid\u2013Ethanol Drug-Drug Interaction: Reversal of Toxicity with Monocarboxylate Transporter 1 Inhibitors"],"prefix":"10.1016","volume":"378","author":[{"given":"Vivian","family":"Rodriguez-Cruz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn E","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.121.000566_bib1","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1038\/npp.2017.110","article-title":"Gamma-hydroxybutyrate increases resting-state limbic perfusion and body and emotion awareness in humans","volume":"42","author":"Bosch","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.121.000566_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1570159X13666141210215423","article-title":"GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome","volume":"13","author":"Busard\u00f2","year":"2015","journal-title":"Curr Neuropharmacol"},{"key":"10.1124\/jpet.121.000566_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2009.04.012","article-title":"Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse","volume":"104","author":"Carter","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.121.000566_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00213-005-0276-0","article-title":"Effects of combining ethanol (EtOH) with gamma-hydroxybutyrate (GHB) on the discriminative stimulus, locomotor, and motor-impairing functions of GHB in mice","volume":"185","author":"Cook","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.121.000566_bib5","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1124\/dmd.109.027169","article-title":"The drug of abuse gamma-hydroxybutyrate is a substrate for sodium-coupled monocarboxylate transporter (SMCT) 1 (SLC5A8): characterization of SMCT-mediated uptake and inhibition","volume":"37","author":"Cui","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.121.000566_bib6","doi-asserted-by":"crossref","first-page":"69219","DOI":"10.18632\/oncotarget.18215","article-title":"Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt\u2019s lymphoma anti-tumor activity","volume":"8","author":"Curtis","year":"2017","journal-title":"Oncotarget"},{"key":"10.1124\/jpet.121.000566_bib7","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1124\/jpet.109.165381","article-title":"Concentration-effect relationships for the drug of abuse gamma-hydroxybutyric acid","volume":"333","author":"Felmlee","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.121.000566_bib8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1208\/s12248-010-9197-x","article-title":"Mechanistic toxicokinetic model for gamma-hydroxybutyric acid: inhibition of active renal reabsorption as a potential therapeutic strategy","volume":"12","author":"Felmlee","year":"2010","journal-title":"AAPS J"},{"key":"10.1124\/jpet.121.000566_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1124\/jpet.119.256503","article-title":"Treatment of \u03b3-hydroxybutyric acid and \u03b3-butyrolactone overdose with two potent monocarboxylate transporter 1 inhibitors, AZD3965 and AR-C155858","volume":"370","author":"Follman","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.121.000566_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1071\/SH17159","article-title":"Low levels of chemsex among men who have sex with men, but high levels of risk among men who engage in chemsex: analysis of a cross-sectional online survey across four countries","volume":"15","author":"Frankis","year":"2018","journal-title":"Sex Health"},{"key":"10.1124\/jpet.121.000566_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11095-019-2735-z","article-title":"Pharmacokinetics of the monocarboxylate transporter 1 inhibitor AZD3965 in mice: potential enterohepatic circulation and target-mediated disposition","volume":"37","author":"Guan","year":"2019","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.121.000566_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mam.2012.05.003","article-title":"The SLC16 gene family - structure, role and regulation in health and disease","volume":"34","author":"Halestrap","year":"2013","journal-title":"Mol Aspects Med"},{"key":"10.1124\/jpet.121.000566_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.forsciint.2016.11.039","article-title":"An observed rise in \u03b3-hydroxybutyrate-associated deaths in London: Evidence to suggest a possible link with concomitant rise in chemsex","volume":"270","author":"Hockenhull","year":"2017","journal-title":"Forensic Sci Int"},{"key":"10.1124\/jpet.121.000566_bib14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1037\/a0031692","article-title":"Comparative abuse liability of GHB and ethanol in humans","volume":"21","author":"Johnson","year":"2013","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1124\/jpet.121.000566_bib15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/00952990701312316","article-title":"High-risk behaviors and hospitalizations among gamma hydroxybutyrate (GHB) users","volume":"33","author":"Kim","year":"2007","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1124\/jpet.121.000566_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13049-016-0299-z","article-title":"Presentations to an urban emergency department in Switzerland due to acute \u03b3-hydroxybutyrate toxicity","volume":"24","author":"Liakoni","year":"2016","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"10.1124\/jpet.121.000566_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1208\/s12248-008-9035-6","article-title":"Overview of the proton-coupled MCT (SLC16A) family of transporters: characterization, function and role in the transport of the drug of abuse gamma-hydroxybutyric acid","volume":"10","author":"Morris","year":"2008","journal-title":"AAPS J"},{"key":"10.1124\/jpet.121.000566_bib18","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1124\/jpet.105.083253","article-title":"Renal clearance of gamma-hydroxybutyric acid in rats: increasing renal elimination as a detoxification strategy","volume":"313","author":"Morris","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.121.000566_bib19","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1208\/s12248-017-0110-8","article-title":"SLC and ABC transporters: expression, localization, and species differences at the blood-brain and the blood-cerebrospinal fluid barriers","volume":"19","author":"Morris","year":"2017","journal-title":"AAPS J"},{"key":"10.1124\/jpet.121.000566_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/jpet.112.202796","article-title":"Effects of monocarboxylate transporter inhibition on the oral toxicokinetics\/toxicodynamics of \u03b3-hydroxybutyrate and \u03b3-butyrolactone","volume":"345","author":"Morse","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.121.000566_bib21","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1124\/jpet.113.206250","article-title":"Toxicokinetics\/toxicodynamics of \u03b3-hydroxybutyrate-ethanol intoxication: evaluation of potential treatment strategies","volume":"346","author":"Morse","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.121.000566_bib22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1124\/mol.112.078154","article-title":"\u03b3-Hydroxybutyrate (GHB)-induced respiratory depression: combined receptor-transporter inhibition therapy for treatment in GHB overdose","volume":"82","author":"Morse","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.121.000566_bib23","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3324\/haematol.2016.163030","article-title":"Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma","volume":"102","author":"Noble","year":"2017","journal-title":"Haematologica"},{"key":"10.1124\/jpet.121.000566_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1432-2277.2012.01579.x","article-title":"Immunosuppressive properties of a series of novel inhibitors of the monocarboxylate transporter MCT-1","volume":"26","author":"P\u00e5hlman","year":"2013","journal-title":"Transpl Int"},{"issue":"suppl 3","key":"10.1124\/jpet.121.000566_bib25","doi-asserted-by":"crossref","first-page":"III9","DOI":"10.1093\/annonc\/mdy048.008","article-title":"A first-in-human first-in-class (FIC) trial of the monocarboxylate transporter 1 (MCT1) inhibitor AZD3965 in patients with advanced solid tumours","volume":"29","author":"Plummer","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1124\/jpet.121.000566_bib26","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1002\/hbm.24532","article-title":"Recreational use of GHB is associated with alterations of resting state functional connectivity of the central executive and default mode networks","volume":"40","author":"Raposo Pereira","year":"2019","journal-title":"Hum Brain Mapp"},{"key":"10.1124\/jpet.121.000566_bib27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1124\/dmd.111.041749","article-title":"Brain uptake of the drug of abuse \u03b3-hydroxybutyric acid in rats","volume":"40","author":"Roiko","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.121.000566_bib28","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s11095-013-0973-z","article-title":"Brain extracellular \u03b3-hydroxybutyrate concentrations are decreased by L-lactate in rats: role in the treatment of overdoses","volume":"30","author":"Roiko","year":"2013","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.121.000566_bib29","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/01.jcp.0000237944.57893.28","article-title":"Gamma-hydroxybutyrate and ethanol effects and interactions in humans","volume":"26","author":"Thai","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/jpet.121.000566_bib30","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2174\/13816128113199990462","article-title":"Role of monocarboxylate transporters in drug delivery to the brain","volume":"20","author":"Vijay","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1124\/jpet.121.000566_bib31","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1007\/s11095-014-1583-0","article-title":"A novel monocarboxylate transporter inhibitor as a potential treatment strategy for \u03b3-hydroxybutyric acid overdose","volume":"32","author":"Vijay","year":"2015","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.121.000566_bib32","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s11095-006-9228-6","article-title":"Monocarboxylate transporter (MCT) mediates the transport of gamma-hydroxybutyrate in human kidney HK-2 cells","volume":"24","author":"Wang","year":"2007","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.121.000566_bib33","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1124\/jpet.106.105965","article-title":"Transport of \u03b3-hydroxybutyrate in rat kidney membrane vesicles: role of monocarboxylate transporters","volume":"318","author":"Wang","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.121.000566_bib34","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1124\/dmd.108.022996","article-title":"Effects of L-lactate and D-mannitol on gamma-hydroxybutyrate toxicokinetics and toxicodynamics in rats","volume":"36","author":"Wang","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.121.000566_bib35","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1124\/jpet.121.000566_bib36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ajem.2009.11.008","article-title":"Case series of 226 \u03b3-hydroxybutyrate-associated deaths: lethal toxicity and trauma","volume":"29","author":"Zvosec","year":"2011","journal-title":"Am J Emerg Med"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524256895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524256895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.121.000566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:52:41Z","timestamp":1739973161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524256895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0022356524256895"],"URL":"https:\/\/doi.org\/10.1124\/jpet.121.000566","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b3-Hydroxybutyric Acid\u2013Ethanol Drug-Drug Interaction: Reversal of Toxicity with Monocarboxylate Transporter 1 Inhibitors","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.121.000566","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}